(Source: Dimension Therapeutics Inc) CAMBRIDGE, MASS, October 21, 2015- Dimension Therapeutics, Inc. ('Dimension' or the 'Company'), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases, today announced the pricing of its initial public offering of 5,500,000 shares of its common stock at a public offering price of $13.00 per share. Dimension's underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares of common stock at the public...
↧